Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 538

1.

Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.

Rizk DV, Silva AL, Pergola PE, Toto R, Warnock DG, Chin MP, Goldsberry A, O'Grady M, Meyer CJ, McCullough PA.

Cardiorenal Med. 2019 Jun 6:1-10. doi: 10.1159/000500612. [Epub ahead of print]

PMID:
31170712
2.

Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure.

Ahmad FS, Kallen MA, Schifferdecker KE, Carluzzo KL, Yount SE, Gelow JM, McCullough PA, Kimmel SE, Fisher ES, Cella D.

Circ Heart Fail. 2019 Jun;12(6):e005751. doi: 10.1161/CIRCHEARTFAILURE.118.005751. Epub 2019 Jun 5.

PMID:
31163985
3.

Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse Outcomes.

Rangaswami J, McCullough PA.

JACC Heart Fail. 2019 Jun;7(6):533. doi: 10.1016/j.jchf.2019.01.005. No abstract available.

PMID:
31146878
4.

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.

Spinowitz BS, Fishbane S, Pergola PE, Roger SD, Lerma EV, Butler J, von Haehling S, Adler SH, Zhao J, Singh B, Lavin PT, McCullough PA, Kosiborod M, Packham DK; ZS-005 Study Investigators.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):798-809. doi: 10.2215/CJN.12651018. Epub 2019 May 20.

PMID:
31110051
5.

The healthcare burden of disease progression in medicare patients with functional mitral regurgitation.

McCullough PA, Mehta HS, Cork DP, Barker CM, Gunnarsson C, Mollenkopf S, Van Houten J, Verta P.

J Med Econ. 2019 Jun 7:1-8. doi: 10.1080/13696998.2019.1621325. [Epub ahead of print]

PMID:
31104524
6.

Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America.

Vijayaraghavan K, McCullough PA, Singh B, Gupta M, Enas E, Mohan V, Misra A, Deedwania P, Brinton EA; for the Consensus Panel Steering Committee .

Cardiorenal Med. 2019 May 10;9(4):240-251. doi: 10.1159/000499341. [Epub ahead of print]

7.

Community-Acquired Acute Kidney Injury as a Risk Factor of de novo Heart Failure Hospitalization.

Tecson KM, Hashemi H, Afzal A, Gong TA, Kale P, McCullough PA.

Cardiorenal Med. 2019 May 10;9(4):252-260. doi: 10.1159/000499669. [Epub ahead of print]

PMID:
31079099
8.

Key updates in Cardio-Nephrology from 2018: springboard to a bright Future.

Rangaswami J, Soman S, McCullough PA.

Rev Cardiovasc Med. 2018 Dec 30;19(4):113-116. doi: 10.31083/j.rcm.2018.04.896. No abstract available.

PMID:
31064161
9.

Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions.

Sudhakaran S, Bottiglieri T, Tecson KM, Kluger AY, McCullough PA.

Rev Cardiovasc Med. 2018 Sep 30;19(3):77-88. doi: 10.31083/j.rcm.2018.03.908.

PMID:
31054556
10.

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA; Conference Participants.

Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.

PMID:
31053387
11.

Arterial Stiffness in the Heart Disease of CKD.

Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P.

J Am Soc Nephrol. 2019 Jun;30(6):918-928. doi: 10.1681/ASN.2019020117. Epub 2019 Apr 30.

PMID:
31040188
12.

Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2.

McCullough PA, Kluger AY, Tecson KM, Barbin CM, Lee AY, Lerma EV, Rosol ZP, Kluger SL, Rangaswami J.

Rev Cardiovasc Med. 2018 Jun 30;19(2):51-63. doi: 10.31083/j.rcm.2018.02.021.

PMID:
31032603
13.

Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review.

Kluger AY, Tecson KM, Barbin CM, Lee AY, Lerma EV, Rosol ZP, Rangaswami J, Lepor NE, Cobble ME, McCullough PA.

Rev Cardiovasc Med. 2018 Jun 30;19(2):41-49. doi: 10.31083/j.rcm.2018.02.907.

PMID:
31032602
14.

Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen.

Zhang J, Rocha NA, McCullough PA.

Rev Cardiovasc Med. 2018 Mar 30;19(1):13-19. doi: 10.31083/j.rcm.2018.01.890.

PMID:
31032598
15.

Key Updates in Cardio-Nephrology from 2018: Springboard to a Bright Future.

Rangaswami J, Soman S, McCullough PA.

Cardiorenal Med. 2019 Apr 17;9(4):222-228. doi: 10.1159/000498916. [Epub ahead of print] No abstract available.

16.

Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies.

Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dalal P, Kapoor R, Lerma EV, Lerman M, McCormick N, Bangalore S, McCullough PA, Dadhania DM.

Nephrol Dial Transplant. 2019 May 1;34(5):760-773. doi: 10.1093/ndt/gfz053.

PMID:
30984976
17.

Common laboratory parameters as indicators of multi-organ dysfunction in acute heart failure.

Sudhakaran S, McCullough PA.

Eur J Heart Fail. 2019 Jun;21(6):751-753. doi: 10.1002/ejhf.1466. Epub 2019 Apr 11. No abstract available.

PMID:
30972928
18.

Comparison of reflex, resistance training, and core activities using change in blood pressure over time after spontaneous coronary artery dissection.

Brown K, Adams J, McCullough PA.

Proc (Bayl Univ Med Cent). 2019 Jan 14;32(1):113-115. doi: 10.1080/08998280.2018.1533308. eCollection 2019 Jan.

19.

Analysis of electrocardiographic intervals before and after transcatheter aortic valve implantation to predict the need for permanent pacing.

Ball TN, Vasudevan A, Mi Ko J, Assar MD, McCullough PA, Stoler RC.

Proc (Bayl Univ Med Cent). 2018 Sep 11;31(4):407-413. doi: 10.1080/08998280.2018.1471884. eCollection 2018 Oct.

20.

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.

Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology.

Circulation. 2019 Apr 16;139(16):e840-e878. doi: 10.1161/CIR.0000000000000664.

PMID:
30852913
21.

Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials.

Rocha NA, McCullough PA.

Kidney Int Suppl (2011). 2018 Jan;8(1):8-17. doi: 10.1016/j.kisu.2017.10.004. Epub 2017 Dec 29. Review.

22.

Event dependence in the analysis of cardiovascular readmissions postpercutaneous coronary intervention.

Vasudevan A, Choi JW, Feghali GA, Lander SR, Jialiang L, Schussler JM, Stoler RC, Vallabhan RC, Velasco CE, McCullough PA.

J Investig Med. 2019 Jan 18. pii: jim-2018-000873. doi: 10.1136/jim-2018-000873. [Epub ahead of print]

PMID:
30659091
23.
24.

In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States.

Goyal A, Chatterjee K, Mathew RO, Sidhu MS, Bangalore S, McCullough PA, Rangaswami J.

Cardiorenal Med. 2019;9(1):51-60. doi: 10.1159/000492731. Epub 2018 Nov 14.

PMID:
30428461
25.

Heart Failure in End-Stage Kidney Disease: Pathophysiology, Diagnosis, and Therapeutic Strategies.

Rangaswami J, McCullough PA.

Semin Nephrol. 2018 Nov;38(6):600-617. doi: 10.1016/j.semnephrol.2018.08.005. Review.

PMID:
30413254
26.

Cardiorenal Syndrome: A Call to Action for a Pressing Medical Issue.

McCullough PA, Soman S.

Adv Chronic Kidney Dis. 2018 Sep;25(5):379-381. doi: 10.1053/j.ackd.2018.08.011. No abstract available.

PMID:
30309454
27.

Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures.

McCullough PA, Todoran TM, Brilakis ES, Ryan MP, Gunnarsson C.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E90-E97. doi: 10.1002/ccd.27807. Epub 2018 Oct 2.

PMID:
30280476
28.

Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction.

Ambrosy AP, Mulder H, Coles A, Krauss WE, Lam CSP, McCullough PA, Pina I, Tromp J, Whellan DJ, O'Connor CM, Mentz RJ.

Am J Cardiol. 2018 Sep 15;122(6):999-1007. doi: 10.1016/j.amjcard.2018.06.011. Epub 2018 Jun 23.

PMID:
30269900
29.

Semaglutide and GLP-1 analogues as weight-loss agents.

Kluger AY, McCullough PA.

Lancet. 2018 Aug 25;392(10148):615-616. doi: 10.1016/S0140-6736(18)31826-9. Epub 2018 Aug 16. No abstract available.

PMID:
30122306
30.

Cardionephrology: Proposal for a Futuristic Educational Approach to a Contemporary Need.

Kazory A, McCullough PA, Rangaswami J, Ronco C.

Cardiorenal Med. 2018;8(4):296-301. doi: 10.1159/000490744. Epub 2018 Aug 8. Review.

31.

Detection of Atherosclerotic Cardiovascular Disease in Patients with Advanced Chronic Kidney Disease in the Cardiology and Nephrology Communities.

Chaudhry RI, Mathew RO, Sidhu MS, Sidhu-Adler P, Lyubarova R, Rangaswami J, Salman L, Asif A, Fleg JL, McCullough PA, Maddux F, Bangalore S.

Cardiorenal Med. 2018;8(4):285-295. doi: 10.1159/000490768. Epub 2018 Aug 3.

32.

Effects of sodium glucose co-transporter 2 inhibitors on the kidney.

de Albuquerque Rocha N, Neeland IJ, McCullough PA, Toto RD, McGuire DK.

Diab Vasc Dis Res. 2018 Sep;15(5):375-386. doi: 10.1177/1479164118783756. Epub 2018 Jul 2. Review.

PMID:
29963920
33.

Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure.

McCullough PA, Uhlig K, Neylan JF, Pergola PE, Fishbane S.

Am J Cardiol. 2018 Aug 15;122(4):683-688. doi: 10.1016/j.amjcard.2018.04.062. Epub 2018 May 19.

34.

Bioimpedance-Guided Hydration for the Prevention of Contrast-Induced Kidney Injury: The HYDRA Study.

Maioli M, Toso A, Leoncini M, Musilli N, Grippo G, Ronco C, McCullough PA, Bellandi F.

J Am Coll Cardiol. 2018 Jun 26;71(25):2880-2889. doi: 10.1016/j.jacc.2018.04.022.

PMID:
29929610
35.

Identifying suspected familial chylomicronemia syndrome.

Rengarajan R, McCullough PA, Chowdhury A, Tecson KM.

Proc (Bayl Univ Med Cent). 2018 May 21;31(3):284-288. doi: 10.1080/08998280.2018.1463784. eCollection 2018 Jul.

36.

Frequency of atrial arrhythmias after atrial flutter ablation and the effect of presenting rhythm on the day of ablation.

Vasudevan A, Hundae A, Borodge D, McCullough PA, Wells PJ.

Proc (Bayl Univ Med Cent). 2018 May 14;31(3):280-283. doi: 10.1080/08998280.2018.1464305. eCollection 2018 Jul.

37.

Frequency of abnormal fractional flow reserve measurements among major coronary arteries.

Barbin CM, Vasudevan A, Choi JW, McCullough PA, Schussler JM, Vallabhan RC, Stoler RC.

Cardiovasc Revasc Med. 2019 Feb;20(2):143-146. doi: 10.1016/j.carrev.2018.04.015. Epub 2018 Apr 25.

PMID:
29807815
38.

Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease: Potential for Targeting Inflammation With Canakinumab.

Cherney DZI, Lytvyn Y, McCullough PA.

J Am Coll Cardiol. 2018 May 29;71(21):2415-2418. doi: 10.1016/j.jacc.2018.04.008. No abstract available.

39.

Editorial: Robertsonian Perspectives on Atherosclerosis: The Power of Direct Observation.

McCullough PA.

Am J Cardiol. 2018 Jun 1;121(11):1441. doi: 10.1016/j.amjcard.2018.02.019. Epub 2018 Apr 3. No abstract available.

PMID:
29724407
40.

Usefulness of alirocumab and evolocumab for the treatment of patients with diabetic dyslipidemia.

Zhang J, Tecson KM, Rocha NA, McCullough PA.

Proc (Bayl Univ Med Cent). 2018 Apr 11;31(2):180-184. doi: 10.1080/08998280.2018.1441255. eCollection 2018 Apr. Review.

41.

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.

Haase VH, Chertow GM, Block GA, Pergola PE, deGoma EM, Khawaja Z, Sharma A, Maroni BJ, McCullough PA.

Nephrol Dial Transplant. 2019 Jan 1;34(1):90-99. doi: 10.1093/ndt/gfy055.

42.

Preeclampsia as a Form of Type 5 Cardiorenal Syndrome: An Underrecognized Entity in Women's Cardiovascular Health.

Rangaswami J, Naranjo M, McCullough PA.

Cardiorenal Med. 2018;8(2):160-172. doi: 10.1159/000487646. Epub 2018 Apr 4. Review.

43.

The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome.

Virzì GM, Zhang J, Nalesso F, Ronco C, McCullough PA.

Cardiorenal Med. 2018;8(2):92-104. doi: 10.1159/000485937. Epub 2018 Jan 22. Review.

44.

Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy.

Maisel AS, Daniels LB, Anand IS, McCullough PA, Chow SL.

Postgrad Med. 2018 Apr;130(3):299-307. doi: 10.1080/00325481.2018.1440873. Epub 2018 Mar 29. Review.

PMID:
29596012
45.

Interpreting the Wide Range of NT-proBNP Concentrations in Clinical Decision Making.

McCullough PA, Kluger AY.

J Am Coll Cardiol. 2018 Mar 20;71(11):1201-1203. doi: 10.1016/j.jacc.2018.01.056. No abstract available.

46.

Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details.

Rangaswami J, McCullough PA.

JACC Heart Fail. 2018 Mar;6(3):266-267. doi: 10.1016/j.jchf.2018.01.010. No abstract available.

47.

Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).

McCullough PA, Ballantyne CM, Sanganalmath SK, Langslet G, Baum SJ, Shah PK, Koren A, Mandel J, Davidson MH.

Am J Cardiol. 2018 Apr 15;121(8):940-948. doi: 10.1016/j.amjcard.2017.12.040. Epub 2018 Feb 2.

48.

Major Adverse Renal and Cardiac Events After Coronary Angiography and Cardiac Surgery.

Tecson KM, Brown D, Choi JW, Feghali G, Gonzalez-Stawinski GV, Hamman BL, Hebeler R, Lander SR, Lima B, Potluri S, Schussler JM, Stoler RC, Velasco C, McCullough PA.

Ann Thorac Surg. 2018 Jun;105(6):1724-1730. doi: 10.1016/j.athoracsur.2018.01.010. Epub 2018 Feb 2.

PMID:
29408241
49.

Plasma Volume and Renal Function Predict Six-Month Survival after Hospitalization for Acute Decompensated Heart Failure.

Bilchick KC, Chishinga N, Parker AM, Zhuo DX, Rosner MH, Smith LA, Mwansa H, Blackwell JN, McCullough PA, Mazimba S.

Cardiorenal Med. 2017 Dec;8(1):61-70. doi: 10.1159/000481149. Epub 2017 Nov 3.

50.

The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty.

Keuffel E, McCullough PA, Todoran TM, Brilakis ES, Palli SR, Ryan MP, Gunnarsson C.

J Med Econ. 2018 Apr;21(4):356-364. doi: 10.1080/13696998.2017.1415912. Epub 2017 Dec 15.

PMID:
29226736

Supplemental Content

Loading ...
Support Center